In addition to planning for, achieving and monitoring genomic and metabolic diversity in our study design and execution, GSK recognizes several demographic dimensions within inclusive clinical operations.
Help streamline the path to regulatory and commercial success to optimize health outcomes for the greatest number of patients
Join the Integrated Evidence Plans project
